- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:46 | Apnimed sets sights on sleep apnoea pill approval following Phase III win | ||
| 13:46 | Novo Nordisk defeated in Wegovy patent dispute by Viatris | ||
| 13:46 | Kling Bio and Sanofi link for antibodies and epitopes discovery | ||
| 13:46 | How ICH E6 (R3) is changing clinical trials | ||
| 12:46 | Exploring AI-powered cell simulations and the launch of the world's first virtual lab | ||
| 11:46 | Janssen's Darzalex new indication gains EC approval for SMM | ||
| Mi | UK enacts law to decentralise manufacture of personalised treatments | ||
| Mi | AstraZeneca announces $50bn US investment plans by 2030 | ||
| Mi | Sanofi to acquire Vicebio's share capital for $1.15bn upfront | ||
| Di | J&J seeks FDA approval for icotrokinra to treat psoriasis | ||
| Di | Sarepta halts Elevidys shipments following FDA pressure | ||
| Di | Biogen to invest further $2bn in North Carolina's Research Triangle Park | ||
| Mo | Life sciences VC Omega Funds closes $647m funding round | ||
| Mo | Sarepta refuses to pull gene therapy despite FDA order | ||
| Mo | Five considerations when scaling up mAbs in partnership with a CDMO | ||
| Mo | CDMO insights podcast series: Our Experience is Your Strength | Episode #2 Gene Therapy Fill-Finish | ||
| Mo | Sanofi concludes Blueprint Medicines acquisition | ||
| Mo | Fangzhou and Novo Nordisk link on chronic disease management | ||
| Fr | Astellas and KISED link to support Korean pharma startups | ||
| Fr | ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing | ||
| Fr | FDA approves GSK's prefilled syringe presentation of Shingrix | ||
| Fr | Can rare disease research in the US thrive under the new administration? | ||
| 17.07. | Ten years of Rare Pediatric Disease Designation: impact on drug approvals | ||
| 17.07. | Sarepta Therapeutics to cut 500 jobs amid restructuring | ||
| 17.07. | Thermo Fisher acquires Sanofi's steriles manufacturing site in US |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .